These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 15205080

  • 1. Central venous line thrombosis in children and young adults with thalassemia major.
    Finkelstein Y, Yaniv I, Berant M, Zilber R, Garty BZ, Epstein O, Lahav J, Tamary H.
    Pediatr Hematol Oncol; 2004; 21(5):375-81. PubMed ID: 15205080
    [Abstract] [Full Text] [Related]

  • 2. Significant association with location of central venous line placement and risk of venous thrombosis in children.
    Male C, Julian JA, Massicotte P, Gent M, Mitchell L, PROTEKT Study Group.
    Thromb Haemost; 2005 Sep; 94(3):516-21. PubMed ID: 16268465
    [Abstract] [Full Text] [Related]

  • 3. DKA, CVL and DVT. Increased risk of deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous lines.
    Davis J, Surendran T, Thompson S, Corkey C.
    Ir Med J; 2007 Jan; 100(1):344. PubMed ID: 17380929
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of thrombotic children with malignancy.
    Unal S, Varan A, Yalçin B, Büyükpamukçu M, Gürgey A.
    Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
    [Abstract] [Full Text] [Related]

  • 5. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ, Göbel U, Christaras A, Janssen G.
    Klin Padiatr; 2005 Jun; 217(3):120-5. PubMed ID: 15858702
    [Abstract] [Full Text] [Related]

  • 6. Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.
    Tamary H, Goshen J, Carmi D, Yaniv I, Kaplinsky C, Cohen IJ, Zaizov R.
    Isr J Med Sci; 1994 Aug; 30(8):658-64. PubMed ID: 8045754
    [Abstract] [Full Text] [Related]

  • 7. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.
    Ruud E, Holmstrøm H, De Lange C, Hogstad EM, Wesenberg F.
    Acta Paediatr; 2006 Sep; 95(9):1053-9. PubMed ID: 16938749
    [Abstract] [Full Text] [Related]

  • 8. Incidence and diagnosis of thrombosis in children with short-term central venous lines of the upper venous system.
    Hanslik A, Thom K, Haumer M, Kitzmüller E, Albinni S, Wolfsberger M, Salzer-Muhar U, Male C.
    Pediatrics; 2008 Dec; 122(6):1284-91. PubMed ID: 19047247
    [Abstract] [Full Text] [Related]

  • 9. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
    McLean TW, Fisher CJ, Snively BM, Chauvenet AR.
    J Clin Oncol; 2005 May 01; 23(13):3024-9. PubMed ID: 15860859
    [Abstract] [Full Text] [Related]

  • 10. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
    Shamsian BS, Aminasnafi A, Moghadassian H, Gachkar L, Arzanian MT, Alavi S, Esfehani H, Garallahi F, Amini R.
    Pediatr Hematol Oncol; 2008 Sep 01; 25(6):502-8. PubMed ID: 18728969
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis of venous thromboembolism in children.
    Male C, Kuhle S, Mitchell L.
    Semin Thromb Hemost; 2003 Aug 01; 29(4):377-90. PubMed ID: 14517750
    [Abstract] [Full Text] [Related]

  • 12. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H.
    Eur J Haematol; 2005 Feb 01; 74(2):93-100. PubMed ID: 15654898
    [Abstract] [Full Text] [Related]

  • 13. Study of intermittent intravenous deferrioxamine high-dose therapy in heavily iron-loaded children with beta-thalassemia major poorly compliant to subcutaneous injections.
    Wali YA, Taqi A, Deghaidi A.
    Pediatr Hematol Oncol; 2004 Feb 01; 21(5):453-60. PubMed ID: 15205089
    [Abstract] [Full Text] [Related]

  • 14. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.
    Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP.
    Ann N Y Acad Sci; 2005 Feb 01; 1054():486-91. PubMed ID: 16339703
    [Abstract] [Full Text] [Related]

  • 15. Thromboembolism in children with sarcoma.
    Athale U, Cox S, Siciliano S, Chan AK.
    Pediatr Blood Cancer; 2007 Aug 01; 49(2):171-6. PubMed ID: 16991135
    [Abstract] [Full Text] [Related]

  • 16. Deep venous thrombosis in children and adolescents.
    Levy ML, Granville RC, Hart D, Meltzer H.
    J Neurosurg; 2004 Aug 01; 101(1 Suppl):32-7. PubMed ID: 16206969
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for venous thromboembolism in children.
    Gerotziafas GT.
    Int Angiol; 2004 Sep 01; 23(3):195-205. PubMed ID: 15765033
    [Abstract] [Full Text] [Related]

  • 18. Pulmonary thromboembolism in childhood: a single-center experience from Turkey.
    Tavil B, Kuskonmaz B, Kiper N, Cetin M, Gumruk F, Gurgey A.
    Heart Lung; 2009 Sep 01; 38(1):56-65. PubMed ID: 19150531
    [Abstract] [Full Text] [Related]

  • 19. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
    Athale U, Siciliano S, Thabane L, Pai N, Cox S, Lathia A, Khan A, Armstrong A, Chan AK.
    Pediatr Blood Cancer; 2008 Dec 01; 51(6):792-7. PubMed ID: 18798556
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients.
    Abdelkefi A, Ben Romdhane N, Kriaa A, Chelli M, Torjman L, Ladeb S, Ben Othman T, Lakhal A, Guermazi S, Ben Hassen A, Ladeb F, Ben Abdeladhim A.
    Bone Marrow Transplant; 2005 Nov 01; 36(10):885-9. PubMed ID: 16151418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.